Basta Steven L has filed 17 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 12362 shares of Phathom Pharmaceuticals, Inc. ($PHAT) on February 10, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 10, 2026 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | A | Common Stock | 12362 | $0.00 | 379,592.0000 | 73,396,435 | 3.37% | 0.02% |
| Feb. 10, 2026 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | F | Common Stock | 6277 | $12.82 | 373,315.0000 | 73,396,435 | 1.65% | 0.01% |
| Jan. 2, 2026 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | A | Stock Option (Right to Buy) | 226156 | $0.00 | 221,156.0000 | 73,396,435 | 0.00% | 0.31% |
| Jan. 2, 2026 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | A | Common Stock | 251034 | $0.00 | 364,820.0000 | 73,396,435 | 220.62% | 0.34% |
| Dec. 17, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | A | Common Stock | 62038 | $0.00 | 145,288.0000 | 73,396,435 | 74.52% | 0.08% |
| Dec. 17, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | F | Common Stock | 31502 | $15.36 | 113,786.0000 | 73,396,435 | 21.68% | 0.04% |
| Dec. 12, 2025 | VYNE Therapeutics Inc. | $VYNE | Basta Steven L | Not found | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 42,589,000 | 9999.99% | 0.05% |
| Nov. 28, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | F | Common Stock | 48375 | $15.62 | 83,250.0000 | 73,396,435 | 36.75% | 0.07% |
| Nov. 28, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | M | Common Stock | 90000 | $0.00 | 131,625.0000 | 73,396,435 | 216.22% | 0.12% |
| Nov. 28, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | M | Performance Shares | 90000 | $0.00 | 180,000.0000 | 73,396,435 | 33.33% | 0.12% |
| Sept. 25, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | M | Common Stock | 90000 | $0.00 | 90,000.0000 | 63,176,210 | 9999.99% | 0.14% |
| Sept. 25, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | M | Performance Shares | 90000 | $0.00 | 270,000.0000 | 63,176,210 | 25.00% | 0.14% |
| Sept. 25, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | F | Common Stock | 48375 | $11.66 | 41,625.0000 | 63,176,210 | 53.75% | 0.08% |
| April 3, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | A | Stock Option (Right to Buy) | 1085000 | $0.00 | 1,085,000.0000 | 63,176,210 | 9999.99% | 1.72% |
| April 3, 2025 | Phathom Pharmaceuticals, Inc. | $PHAT | Basta Steven L | President and CEO | A | Performance Shares | 360000 | $0.00 | 360,000.0000 | 63,176,210 | 9999.99% | 0.57% |
| Dec. 12, 2024 | VYNE Therapeutics Inc. | $VYNE | Basta Steven L | Not found | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 10,273,000 | 9999.99% | 0.19% |
| Jan. 1, 2024 | VYNE Therapeutics Inc. | $VYNE | Basta Steven L | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 10,273,000 | 9999.99% | 0.19% |